A CXCR4-Targeted Dual-Acting Nanoconjugate Combines Protein-Toxin and Small-Molecule Warheads for Synergistic Cytotoxicity
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.6c00337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Julian I Mendoza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recerca Sant Pau (IR SANT PAU), Barcelona08041, Spain. Hauptthemen laut MEDLINE: Receptors, CXCR4, Nanoconjugates, Oligopeptides, Antineoplastic Agents. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Fundació Investigació Salut i Progress, Agencia Estatal de Investigación.
Abstract (Originalsprache)
Self-assembling multivalent protein nanoparticles with an architecture based on His-metal coordination and specific binding to cancer stem cells have emerged as promising tools for the selective delivery of microbial toxins in oncology, reaching precise cytotoxic effects. The incorporation of small-molecule drugs aimed at improving drug potency has so far been limited by the loss of stability and especially the loss of selectivity of the final products. Here, we have explored a site-specific conjugation method based on the Staphylococcus aureus sortase A, by which a CXCR4-targeted, engineered form of the diphtheria-toxin-derived protein warhead has been covalently enriched with the anti-tumoral agent monomethyl auristatin E (MMAE). The resulting dual-acting nanoscale conjugate exhibits enhanced cytotoxicity over CXCR4+ cells without compromising selectivity in the intracellular delivery process. Interestingly, the combination of the microbial toxin and MMAE, empowered by the multivalent display of the CXCR4-ligand T22, shows significant synergistic cytotoxicity over the target cells. Therefore, the suggested strategy allows not only the design of dual-acting targeted nanoconjugates that combine protein-toxin and small-molecule warheads in precise stoichiometric ratios but also the enhancement of their cytotoxic effects by allowing a synergistic action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Recerca Sant Pau (IR SANT PAU), Barcelona08041, Spain.
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Barcelona08041, Spain.
- Josep Carreras Leukaemia Research Institute, Barcelona08025, Spain.
- Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra08193, Spain.
- Departament d'Òptica i Optometria (DOO), Biomaterials, Biomechanics and Tissue Engineering Group (BBT), Universitat Politècnica de Catalunya-BarcelonaTech (UPC), Terrassa08222, Spain.
- Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra08193, Spain.
ORCID-Profile: Esther Vazquez, Ugutz Unzueta
Förderung
- Instituto de Salud Carlos III
- Fundació Investigació Salut i Progress
- Agencia Estatal de Investigación
Zitieren
APA
Mendoza, J. I., Rueda, A., Quijada, G., Volta-Durán, E., Vazquez, E., Mangues, R., Villaverde, A., & Unzueta, U. (2026). A CXCR4-Targeted Dual-Acting Nanoconjugate Combines Protein-Toxin and Small-Molecule Warheads for Synergistic Cytotoxicity. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00337
Vancouver
Mendoza JI, Rueda A, Quijada G, Volta-Durán E, Vazquez E, Mangues R, et al. A CXCR4-Targeted Dual-Acting Nanoconjugate Combines Protein-Toxin and Small-Molecule Warheads for Synergistic Cytotoxicity. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00337
BibTeX
@article{Mendoza2026,
author = {Mendoza, Julian I and Rueda, Ariana and Quijada, Gemma and Volta-Durán, Eric and Vazquez, Esther and Mangues, Ramon and Villaverde, Antonio and Unzueta, Ugutz},
title = {A CXCR4-Targeted Dual-Acting Nanoconjugate Combines Protein-Toxin and Small-Molecule Warheads for Synergistic Cytotoxicity},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00337}
}
EUVIMED